Rapid evidence profiles
: [74]
Collection home page
Rapid evidence profiles (REPs) address specific questions posed by decision-makers about urgent health- and social-system issues. They are prepared in hours or days and aim to provide an overview of the best available global research evidence (i.e., evidence syntheses) and local research evidence (i.e., single studies) as well as experiences from other countries and from Canadian provinces and territories, but do not provide insights based on an in-depth synthesis of available evidence documents and jurisdictional insights.
Collection's Items (Sorted by Submit Date in Descending order): 61 to 74 of 74
| Publication Date | Title | Author(s) |
| Jul-2020 | COVID-19 rapid evidence profile #15: What frameworks from available evidence and experiences in other countries can inform what needs to be done to plan for future waves of COVID-19? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Bhuiya, AR; Voorheis, P; Ahmad, A; Gao, C; Alam, S; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #14: Where and with what impacts have shifts from in-person to virtual approaches occurred in the delivery of healthcare services in general and mental health and addictions services in particular? | Waddell, K; Bullock, HL; Evans, C; Wilson, MG; Gauvin, François-Pierre; Moat, KA; Mansilla, C; Wang, Q; Bhuiya, AR; Ahmad, A; Filbey, L; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #13: What pandemic-related mental health and addictions issues have emerged and what indicators and strategies can be used to monitor and address them, respectively? | Waddell, K; Wilson, MG; Bullock, HL; Evans, C; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| Jun-2020 | COVID-19 rapid evidence profile #12: What insights from the available evidence and jurisdictional scans can inform who should be tested for COVID-19 and how frequently, where, by whom and with what follow-up actions should they be tested? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #11: What is the evidence related to playground equipment and risk of COVID-19 transmission? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Voorheis, P; Bhuiya, AR; Ahmad, A; Sharma, K; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #10: What screening approaches can be used in non-healthcare settings (e.g., universities, stores and office settings) to identify people who may have COVID-19 and need to take appropriate action? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #8: How effective is temperature taking at borders or in general as a screening tool to identify people who may have COVID-19 and need to take appropriate action? | Wilson, MG; Waddell, K; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| May-2020 | COVID-19 rapid evidence profile #7: What are the international lessons learned from re-opening non-COVID-19 activities in hospitals? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #6: What is known about strategies for supporting the use of masks under shortage conditions to prevent COVID-19? | Waddell, K; Wilson, MG; Gauvin, François-Pierre; Mansilla, C; Moat, KA; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #5: What is known about the use of medical masks by essential non-medical workers to prevent community transmission of COVID-19? | Waddell, K; Gauvin, François-Pierre; Wilson, MG; Moat, KA; Mansilla, C; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #4: What are the most effective non-medical masks for preventing community transmission of COVID-19, and should they be required for all of society? | Wilson, MG; Gauvin, François-Pierre; Moat, KA; Waddell, K; Mansilla, C; Wang, Q; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile # 2: What is known about the spread and management of COVID-19 in non-health workplaces? | Waddell, K; Gauvin, François-Pierre; Wilson, MG; Moat, KA; Mansilla, C; Lavis, JN |
| Apr-2020 | COVID-19 rapid evidence profile #1: What is known about approaches to and safety of conserving, reusing, and repurposing different kinds of masks? | Wilson, MG; Gauvin, François-Pierre; Waddell, K; Moat, KA; Lavis, JN |
Collection's Items (Sorted by Submit Date in Descending order): 61 to 74 of 74
